The Living Guidelines: Patients with Reduced LVEF. Polling Results for CLASS IIb Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIb Guidelines
1. A combination of hydralazine and a nitrate might be reasonable in patients with current or prior symptoms of HF and reduced LVEF who cannot be given an ACEI or ARB because of drug intolerance, hypotension, or renal insufficiency. (Level of Evidence: C)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class IIb Recommendation 1 for patients with reduced LVEF should be: CLASS I CLASS IIa CLASS IIb CLASS III 2. The addition of an ARB may be considered in persistently symptomatic patients with reduced LVEF who are already being treated with conventional therapy. (Level of Evidence: B)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class IIb Recommendation 2 for patients with reduced LVEF should be: CLASS I CLASS IIa CLASS IIb CLASS III